| 产品名称: | huFasM38 |
|---|---|
| 商品货号: | TS211809 |
| Organism: | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type: | hybridoma: B lymphocyte |
| Product Format: | frozen |
| Morphology: | lymphoblast |
| Culture Properties: | suspension |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications: | The antibody reacts with the extracellular domain of human Fas and blocks Fas dependent killing of Jurkat cells (a human T cell line). It inhibits the binding of other Fas specific antibodies, and inhibits Fas-L mediated lysis of T cell targets. |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation: | Spleen cells were fused with P3X63Ag8.653 myeloma cells. |
| Genes Expressed: | immunoglobulin; monoclonal antibody; against human Fas antigen |
| Cellular Products: | immunoglobulin; monoclonal antibody; against human Fas antigen |
| Comments: | Animals were immunized with a fusion protein containing the extracellular protion of human Fas and human IgG1 Fc region. Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibody reacts with the extracellular domain of human Fas and blocks Fas dependent killing of Jurkat cells (a human T cell line). It inhibits the binding of other Fas specific antibodies, and inhibits Fas-L mediated lysis of T cell targets. |
| Complete Growth Medium: | Dulbeccos modified Eagles medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 100 units/mL penicillin, and 0.1 mg/ml streptomycin, 90%; fetal bovine serum, 10%
|
| Subculturing: | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Culture Conditions: | Temperature: 37.0°C |
| Isotype: | IgG1 |
| Name of Depositor: | Immunex Corporation |
| Deposited As: | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number: | |
| References: | Lynch DH, Alderson MR. Human anti-FAS IGG1 monoclonal antibodies. US Patent 5,620,889 dated Apr 15 1997 Lynch DB, Alderson MR. Fas antagonists and uses thereof. US Patent 5,830,469 dated Nov 3 1998 |